Zimmer Biomet Holdings

Zimmer Biomet connects its implants to a broader digital ecosystem called ZBEdge, which leverages data analytics and artificial intelligence. A key example is the Persona IQ smart knee implant, developed with Canary Medical, which captures objective kinematic data post-operatively. The firm also uses its mymobility app to guide patients through pre- and post-operative care, linking patient-reported outcomes with surgical robotics data from systems like the ROSA Knee.

Zimmer Biomet holds an exclusive distribution agreement for the CANARY canturio te, a component of the smart implant ecosystem developed by Canary Medical. Canary Medical manufactures the sensor technology embedded in the Persona IQ smart knee implant. Zimmer Biomet markets and distributes the combined implant and monitoring system globally.

The company addresses the major reconstructive and sports medicine markets. Its primary areas include knee, hip, foot and ankle, shoulder, and sports medicine. Within these, Zimmer Biomet provides everything from primary and revision joint replacement systems—such as the Oxford Cementless Partial Knee and the Persona Revision Knee—to automated surgical tools like the HAMMR Automated Hip Impaction System.

Zimmer Biomet is a pure-play medical device manufacturer and technology company, not an investment firm. As a publicly traded entity, it uses its own R&D budget and corporate balance sheet to fund innovation rather than managing external capital. The firm has maintained a record of delivering shareholder value through dividends and operational growth for over 90 years.

Robotics is central to the firm's growth strategy, primarily through the ROSA robotic surgery platform. The ROSA Knee System assists surgeons in performing total knee arthroplasties by providing real-time data and guidance to improve implant alignment. This robotic platform is designed to integrate seamlessly with Zimmer Biomet's implant families, creating a unified surgical ecosystem.